Hydrogen inhalation alleviates nonalcoholic fatty liver disease in metabolic syndrome rats
Boyan Liu, Junli Xue, Mengyu Zhang, Min Zhao, Mingyue Wang, Qianqian Gu, Shu-Cun Qin, Tingting Ma
Read more:
DOI:
10.3892/mmr.2020.11364
DOI is the universal ID for this study.
This link will take you to the full study.
Abstract:
Hydrogen exhibits therapeutic and preventive effects against various diseases. The present study investigated the potential protective effect and dose‑dependent manner of hydrogen inhalation on high fat and fructose diet (HFFD)‑induced nonalcoholic fatty liver disease (NAFLD) in Sprague‑Dawley rats. Rats were randomly divided into four groups: i) Control group, regular diet/air inhalation; ii) model group, HFFD/air inhalation; iii) low hydrogen group, HFFD/4% hydrogen inhalation; and iv) high hydrogen group, HFFD/67% hydrogen inhalation. After a 10‑week experiment, hydrogen inhalation ameliorated weight gain, abdominal fat index, liver index and body mass index of rats fed with HFFD and lowered the total area under the curve in an oral glucose tolerance test. Hydrogen inhalation also ameliorated the increase in liver lipid content and alanine transaminase and aspartate transaminase activities. Liver histopathologic changes evaluated with hematoxylin and eosin as well as Oil Red O staining revealed lower lipid deposition in hydrogen inhalation groups, consistent with the decrease in the expression of the lipid synthesis gene SREBP‑1c. The majority of the indicators were affected following treatment with hydrogen in a dose‑dependent manner. In conclusion, hydrogen inhalation may play a protective role by influencing the general state, lipid metabolism parameters, liver histology and liver function indicators in the rat model of metabolic syndrome with NAFLD.
| Publish Year |
2020 |
| Country |
China |
| Rank |
Positive |
| Journal |
Molecular Medicine Reports |
| Primary Topic |
Liver |
| Secondary Topic | Liver Disease |
| Model |
Rat |
| Tertiary Topic | Fatty Liver Disease (Nonalcoholic) |
| Vehicle |
Gas |
| pH |
N/A |
| Application |
Inhalation |
| Comparison |
|
| Complement |
|
Hydrogen gas alleviates acute ethanol-induced hepatotoxicity in mice via modulating TLR4/9 innate ...
2023 - Liver - Fatty Liver Disease (Alcoholic)
Alcoholic liver disease (ALD), which is induced by chronic heavy alcohol consumption, accompanies complicated pathological mechanisms, including oxidative stress, inflammation, cell death, epigenetic changes and acetaldehyde-mediated toxicity. ...
Investigating the Effect of Hydrogen-Rich Water on Liver Cell Injury and Liver Cancer by Regulating ...
Background Liver cancer is an extremely heterogeneous malignant disease among tumors identified to date. In recent years, a large number of studies have found that low-concentration hydrogen or hydrogen-rich water or hydrogen-saturated physiological ...
The Effect of Adjuvant Therapy with Molecular Hydrogen on Endogenous Coenzyme Q10 Levels and ...
2023 - Liver - Fatty Liver Disease (Nonalcoholic)
Molecular hydrogen (H2) has been recognized as a novel medical gas with antioxidant and anti-inflammatory effects. Non-alcoholic fatty liver disease (NAFLD) is a liver pathology with increased fat accumulation in liver tissue caused by factors other ...
Alleviating effects of hydrogen on hyperhomocysteinemia and fatty liver induced by high-methionine ...
2023 - Liver - Liver Disease
Objective: To investigate the alleviating effect of hydrogen (H2) on homocysteine (Hcy) levels and non alcoholic fatty liver in rats with hyperhomocysteinemia (HHcy). Methods: After one week of adaptive feeding, Wistar rats were randomly divided into ...
Hydrogen inhalation ameliorates hepatic inflammation and modulates gut microbiota in rats with ...
2023 - Liver - Liver Disease
Nonalcoholic fatty liver disease (NAFLD) is a multisystem metabolic disease associated with gut microflora dysbiosis and inflammation. Hydrogen (H2) is a novel and effective antiinflammatory agent. The present study was aimed to clarify the effects ...
A randomized, placebo-controlled clinical trial of hydrogen/oxygen inhalation for non-alcoholic ...
2022 - Liver - Liver Disease
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide with increasing incidence consistent with obesity, type 2 diabetes and cardiovascular diseases. No approved medication was currently available for NAFLD ...